NCT02649829 2025-04-29
MESODEC
University Hospital, Antwerp
Phase 1/2 Completed
Clinical Trials
8 trialsNCT03874897 2024-04-30
Chimeric Antigen Receptor T Cells Targeting claudin18.2 in Solid Tumors.
Peking University
Phase 1 Completed
NCT05898451 2023-06-12
R-2
Refnot-Pharm Ltd
Phase 2 Completed
NCT05809336 2023-04-12
Gut Microbial Metabolites Inosine Combined With PD-1/PD-L1 Inhibitor for Patients With Malignant Advanced Solid Tumors
Beijing Friendship Hospital
Phase 2/3 Completed
NCT01675765 2020-09-30
Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma
Aduro Biotech, Inc.
Phase 1 Completed
NCT02467426 2015-06-10
Isolated Thoracic Perfusion (ITP-F) for MPM
Medias Klinikum for Surgical Oncology
Completed
NCT00003249 2013-02-07
Carboxyamidotriazole and Ketoconazole in Treating Patients With Advanced Cancers
National Cancer Institute (NCI)
Phase 1 Completed
NCT00003974 2011-03-07
Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma
Roswell Park Cancer Institute
Phase 1 Completed